hotspot -WSS

hotspot

author：leisure time 2025-10-01 02:27:45 - browse：45974

Novo Nordisk headquarters -- health coverage from STAT — Novo Nordisk's headquarters, outside Copenhagen, Denmark. LISELOTTE SABROE/Scanpix/AFP via Getty Images

Novo Nordisk is pausing ads for its obesity drug Wegovy as it struggles to keep up with surging demand, the latest hurdle in its rollout of the weight loss drug.

“To avoid stimulating further demand for this medicine, we’re pausing some key Wegovy promotional efforts,” the Danish drugmaker said in an emailed statement. “We are pausing all local television advertising and postponing planned national television advertising for Wegovy. We are also assessing our promotional efforts to healthcare professionals and adjusting accordingly.” The news was earlier reported by Endpoints.

Wegovy, which contains the active ingredient semaglutide, has become immensely popular for its effectiveness in helping people lose weight and is helping usher in what many see as a sea change in obesity treatment. Its sister drug for diabetes, Ozempic, has also been in demand for a similar effect on weight loss.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Medical students need to learn the potent medicine of empathy

WSS

The world needs the new pandemic treaty

What American doctors can learn from their Israeli counterparts

Ozempic cut risk of death in diabetes patients with chronic kidney disease

NIH nominee Bertagnolli will get October confirmation hearing

Stroke rates rising, especially in working

Guardant Health colon cancer test endorsed by FDA advisory panel

Wikipedia

hotspot

Wikipedia

Anesthesiologist group: stop taking Ozempic before surgery

What American doctors can learn from their Israeli counterparts

Medicare proposal to cover medical devices draws a mixed reaction

Crinetics acromegaly drug succeeds in late

How to save PrEP access — and even expand it

Bird flu makes raw milk dangerous to consume, mouse study finds

Activists slam private health insurers over coverage restrictions

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Medical leaders decry Supreme Court decision on affirmative action

A rare thyroid diagnosis led to unexpected, all

Wikipedia

The (many) problems with a new study criticizing cancer screening

The Bio Revolution is changing business and society

Louisiana bill approved classifying abortion pills as controlled substances

NIH nominee Bertagnolli will get October confirmation hearing

Beyond aggravation: Constipation is an American epidemic

Clinicians often fail to acknowledge the pain caused by long Covid

focus

leisure time

leisure time

knowledge